11.30.15 — Press Release
Study in Science Translational Medicine identifies drug target and genetic pathway for graft-versus-host disease, a...
11.3.15 — Press Release
Hayward replaces Jeff Sconyers, who retired earlier this year
9.17.15 — Press Release
The Neonatal Intuitive Feeding TechnologY (NIFTY™ cup) has the potential to save or improve the lives of millions of infants...
9.10.15 — Press Release
Gene therapy research aims to cure pediatric diseases early in life by targeting and repairing the disease-causing genes in...
8.18.15 — Press Release
New clinic replaces the Seattle Children’s Federal Way facility, which closed on Aug. 12
6.4.15 — Press Release
Tumor Paint BLZ-100 aims to improve surgical outcomes by acting as a molecular flashlight that allows surgeons to visibly...
5.18.15 — Press Release
Children in preschool and daycare settings are only offered 48 of 120 recommended minutes of active play daily, study...
5.17.15 — Press Release
New medication also reduces by 40 percent the number of pulmonary exacerbations, the leading cause of death in cystic...
5.14.15 — Press Release
New position will focus on strategies to ensure that every child and family has access to the healthcare services they...
3.5.15 — Press Release
Sperring joins Seattle Children’s from Riley Hospital for Children, will assume role early May
Please read our press policy before contacting us.
The best way to reach the public relations team is to email firstname.lastname@example.org. To reach us by phone, call 206-987-4500.
Note: This contact information is for members of the media only. For non-media inquiries, call the hospital switchboard at 206-987-2000.
3.19.18 — Fast Co. Design
Dr. Abby Rosenberg and her colleague Dr. Joyce Yi-Frazier of Seattle Children’s created the Promoting Resilience in Stress...
3.14.18 — The Washington Post
Blaze Bioscience is testing Tumor Paint, patented by company co-founder Dr. Jim Olson of Fred Hutch and Seattle Children’s...
3.13.18 — KOMO News
The FDA has approved the first mechanical heart valve designed for infants and babies after a medical trial that started at...